Hippen Benjamin, Matas Arthur
Metrolina Nephrology Associates, P.A., Charlotte, North Carolina, USA.
Curr Opin Organ Transplant. 2009 Apr;14(2):140-6. doi: 10.1097/MOT.0b013e3283295e0d.
Several factors have generated interest in proposals to offer incentives in exchange for kidneys from living donors, including the growing shortage of available organs, the apparent asymptote of traditional means of organ procurement, and the intimate link between the inadequacies of organ procurement policies in developed countries with the flourishing of underground organ trafficking in developing countries.
Herein, we review the scope and dimensions of the growing shortage of organs in the United States, with attention to how each of the proposed solutions to same has proven insufficient. With special attention to the concerns leveled by Gabriel Danovitch in his 'Open Letter,' we conclude that each of his concerns are unfounded, and offer a prospectus on how a trial of such systems might be pursued in the United States.
The failure of current approaches to organ procurement in the United States and other developed countries has led to unnecessary suffering and death, with morally unacceptable consequences for developing countries. For these reasons, a structured trial of incentives for organ procurement in the United States is a moral imperative.
有几个因素引发了人们对为活体捐赠者提供肾脏激励措施提议的兴趣，包括可用器官日益短缺、传统器官获取方式明显趋于极限，以及发达国家器官获取政策的不足与发展中国家地下器官交易猖獗之间的紧密联系。
在此，我们审视了美国器官短缺问题日益严重的范围和程度，并关注了针对该问题提出的每一种解决方案如何被证明是不够的。特别关注加布里埃尔·达诺维奇在其“公开信”中提出的担忧，我们得出结论，他的每一项担忧都毫无根据，并提供了一份关于如何在美国开展此类系统试验的计划书。
美国和其他发达国家目前器官获取方法的失败导致了不必要的痛苦和死亡，给发展中国家带来了道德上不可接受的后果。出于这些原因，在美国对器官获取激励措施进行结构化试验在道德上势在必行。
